Detalles de la búsqueda
1.
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.
Clin Gastroenterol Hepatol
; 21(11): 2889-2900.e10, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871772
2.
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study.
Clin Gastroenterol Hepatol
; 20(2): 458-460.e4, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33775894
3.
Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease.
Dig Dis
; 39(3): 247-257, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32836224
4.
Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.
Transpl Int
; 30(2): 196-208, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27896858
5.
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.
Diabetes Care
; 43(2): 290-297, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31604692
6.
Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study.
Clin Transl Gastroenterol
; 10(4): e00007, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30939489
7.
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus.
J Investig Med
; 67(2): 303-311, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309884
8.
An Unusual Case of Gastritis in One Patient Receiving PD-1 Blocking Therapy: Coexisting Immune-Related Gastritis and Cytomegaloviral Infection.
Gastroenterology Res
; 11(5): 383-387, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30344812
Resultados
1 -
8
de 8
1
Próxima >
>>